Page last updated: 2024-08-21

c.i. 42510 and Fatty Liver, Nonalcoholic

c.i. 42510 has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Y; Du, X; Feitosa, MF; Handelman, SK; Kuppa, A; Palmer, ND; Puentes, YM; Speliotes, EK1

Reviews

1 review(s) available for c.i. 42510 and Fatty Liver, Nonalcoholic

ArticleYear
Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.
    Hepatology communications, 2022, Volume: 6, Issue:11

    Topics: Adenosine Triphosphate; Apolipoproteins; Apolipoproteins B; ATP-Binding Cassette Transporters; Bilirubin; Chloride-Bicarbonate Antiporters; Cholesterol; Cholesterol, LDL; Fatty Acid-Binding Proteins; Fetuin-B; Genome-Wide Association Study; Hormones; Humans; Lipids; Lipoproteins, HDL; Non-alcoholic Fatty Liver Disease; PPAR alpha; Receptors, Cytoplasmic and Nuclear; Retinoid X Receptors; RNA-Binding Proteins; Rosaniline Dyes; Triglycerides

2022